LRQA Calls for Stronger AI Governance and Cyber Resilience Frameworks at CyberSecMY 2026
KUALA LUMPUR, Malaysia, May 22, 2026 /PRNewswire/ -- With AI rapidly reshaping the digital risk landscape, LRQA reinforced the importance of responsible AI governance and evidence-based cybersecurity strategies during CyberSecMY 2026. LRQA Calls for...
BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
BEIJING, May 22, 2026 /PRNewswire/ -- BAI Capital today announced the first close of its latest USD fund, targeting US$800 million. The first close reached US$600 million in commitments. At a time when global capital allocation has become more...
ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
MEXICO CITY, May 22, 2026 /PRNewswire/ -- ESENTIA Energy Development, S.A.B. de C.V. (BMV: ESENTIA) ("ESENTIA" or the "Company") today announced the successful settlement of US$2 billion senior unsecured 144A/Reg S notes offering. The transaction...
Digital Edge Successfully Closes First US$575 Million HoldCo Loan to Accelerate Growth Across Key Asia-Pacific Markets
SINGAPORE, May 22, 2026 /PRNewswire/ -- Digital Edge today announced the successful closing of its inaugural US$575 million holding company ("HoldCo") financing, marking a significant milestone in the company's continued evolution as one of...
Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase III OptiTROP-Lung05 study (Abstract #8506)...
Manulife Hong Kong and Macau Announces CEO Succession
Appoints Wilton Kee as Chief Executive Officer, Succeeding Patrick Graham HONG KONG, May 22, 2026 /PRNewswire/ -- Manulife Hong Kong and Macau today announced strategic changes to its senior leadership team with Wilton Kee appointed to succeed...
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
TAIPEI, May 22, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected...
Chinese and International Cultural Figures Explores Heritage and Innovation in China's Hubei Province
WUHAN, China, May 22, 2026 /PRNewswire/ -- From April 20 to 23, 2026, the event "Where the World Meets Jingchu: Chinese and International Cultural Figures Visit Hubei" took place in Wuhan and Jingzhou. More than 10 Chinese and international cultural...